UK pharma major GSK today announced positive results from its two pivotal Phase III trials, B-Well 1 [NCT05630807] and B-Well ...

Swiss anti-infectives specialist Basilea has struck a research collaboration with US biotech Prokaryotics to develop a ...

UK biotech AstronauTx has appointed Adam Rosenberg as chairman of its board, succeeding Tim Edwards, as the company advances ...

Netherlands-based Scenic Biotech, a company advancing modifier therapy—a radical new approach to treating genetic ...

US healthcare major Johnson & Johnson (NYSE: JNJ) has submitted a Type II variation to the European Medicines Agency seeking ...

Ireland-headquartered Jazz Pharmaceuticals closed Tuesday’s trading 4% lower despite announcing positive efficacy and safety ...

Immune-mediated diseases specialist Alumis has announced positive top-line results from its Phase III ONWARD1 and ONWARD2 ...

Chinese biopharma Hutchmed today announces that the Phase III registration part of the ESLIM-02 clinical trial of sovleplenib ...

Industry groups are urging changes to the US Food and Drug Administration’s Biosimilar User Fee Amendments programme as talks ...

US biotech BostonGene has struck a research collaboration with British pharma AstraZeneca (LSE: AZN) to explore the use of ...

German contract development and manufacturing company ProBioGen has announced the signing of a master service agreement (MSA) ...

New York-based clinical-stage biotech LB Pharmaceuticals had announced the appointments of Ellen Rose as senior vice ...